Begoña
Graña Suárez
![Foto de Begoña](/img/nophoto.png)
![Foto de Hospital Vall d'Hebron](/img/noimage_org.png)
Hospital Vall d'Hebron
Barcelona, EspañaPublicacións en colaboración con investigadores/as de Hospital Vall d'Hebron (16)
2024
-
Prevalence of Homologous Recombination Deficiency Among Patients With Germline RAD51C/D Breast or Ovarian Cancer
JAMA network open, Vol. 7, Núm. 4, pp. e247811
2023
-
SEOM clinical guideline on heritable TP53-related cancer syndrome (2022)
Clinical and Translational Oncology, Vol. 25, Núm. 9, pp. 2627-2633
2018
-
Psychological impact of multigene cancer panel testing in patients with a clinical suspicion of hereditary cancer across Spain
Psycho-Oncology, Vol. 27, Núm. 6, pp. 1530-1537
2016
-
Screening for Lynch syndrome among patients with newly diagnosed endometrial cancer: A comprehensive review
Tumori, Vol. 102, Núm. 6, pp. 548-554
2015
-
SEOM clinical guidelines in Hereditary Breast and ovarian cancer
Clinical and Translational Oncology, Vol. 17, Núm. 12, pp. 956-961
2014
-
Phase I trial of olaparib in combination with cisplatin for the treatment of patients with advanced breast, ovarian and other solid tumors
Annals of Oncology, Vol. 25, Núm. 8, pp. 1656-1663
2013
2012
-
Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancer
Breast Cancer Research and Treatment, Vol. 132, Núm. 1, pp. 307-315
-
What factors may influence psychological well being at three months and one year post BRCA genetic result disclosure?
Breast, Vol. 21, Núm. 6, pp. 755-760
2011
-
Germline ATM mutational analysis in BRCA1/BRCA2 negative hereditary breast cancer families by MALDI-TOF mass spectrometry
Breast Cancer Research and Treatment, Vol. 128, Núm. 2, pp. 573-579
-
International distribution and age estimation of the Portuguese BRCA2 c.156-157insAlu founder mutation
Breast Cancer Research and Treatment, Vol. 127, Núm. 3, pp. 671-679
-
Low penetrance hereditary retinoblastoma in a family: What should we consider in the genetic counselling process and follow up?
Familial Cancer
-
Novel BRCA1 deleterious mutation (c.1949_1950delTA) in a woman of Senegalese descent with triple-negative early-onset breast cancer
Oncology Letters, Vol. 2, Núm. 6, pp. 1287-1289
-
SEOM clinical guidelines for hereditary cancer
Clinical and Translational Oncology, Vol. 13, Núm. 8, pp. 580-586
2009
-
Opinion about reproductive decision making among individuals undergoing BRCA1/2 genetic testing in a multicentre Spanish cohort
Human Reproduction, Vol. 24, Núm. 4, pp. 1000-1006
2008
-
The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain
Clinical Cancer Research, Vol. 14, Núm. 9, pp. 2861-2869